Narges Lashkarbolouk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Narges Lashkarbolouk has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Mahdi Mazandarani
Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
27 shared publications - Lobat Shahkar
Taleghani Pediatric Hospital, Golestan University of Medical Sciences, Gorgan, Iran
6 shared publications - Ali Ahani Azari
Golestan University of Medical Sciences, Gorgan, Iran
5 shared publications - Behnaz Khodabakhshi
Infectious diseases research center, Golestan University of Medical Sciences, Gorgan, Iran
4 shared publications - Mohammad Hadi Tajik Jalayeri
Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
4 shared publications Mohammad Hadi Tajik Jalayeri
Clinical Research Development Unit (CRDU), Sayyad Shirazi Hospital Golestan University of Medical Sciences Gorgan Iran
3 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6262-6271
Evaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients: a double-blind multicenter randomized clinical trial
Background: Chemotherapy-induced peripheral neuropathy is a common non-hematologic complication and a major dose-limiting factor in cancer treatment, potentially reducing patient survival. Duloxetine and venlafaxine, antidepressant drugs, have demonstrated efficacy in managing neuropathic pain associated with diabetes and fibromyalgia in several studies. Methods: In this randomized, double-blind clinical trial, cancer patients undergoing chemotherapy were assessed for neuropathy and pain using the Patient Neurotoxicity Questionnaire and McGill Pain Questionnaire at baseline, 6 weeks, and 12 weeks. Patients were randomized to receive either duloxetine (Group A: 30 mg daily, increasing to 60 mg daily after 1 week), venlafaxine (Group B: 37.5 mg daily, increasing to 75 mg daily after 1 week), or a placebo (Group C). Results: Among 141 randomized patients (61% female; mean age 64.4 years), no significant difference in pain scores was observed between groups at the primary endpoint of week 6 ( P = 0.59). At the secondary endpoint of week 12, a statistically significant difference between groups emerged ( P = 0.03), driven by a reduction in pain scores in the duloxetine group compared with placebo ( post hoc P = 0.03). Within-group reductions were significant for both duloxetine ( P = 0.002) and venlafaxine ( P = 0.007) at 12 weeks. Conclusion: This trial did not meet its primary endpoint at 6 weeks with duloxetine or venlafaxine compared to placebo. Secondary analyses at 12 weeks suggest that only duloxetine may provide clinically meaningful symptom relief. Venlafaxine findings remain inconclusive, as within-group improvements did not translate into statistically significant between-group superiority.
- 3 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6262-6271
Open AccessEvaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients: a double-blind multicenter randomized clinical trial
Background: Chemotherapy-induced peripheral neuropathy is a common non-hematologic complication and a major dose-limiting factor in cancer treatment, potentially reducing patient survival. Duloxetine and venlafaxine, antidepressant drugs, have demonstrated efficacy in managing neuropathic pain associated with diabetes and fibromyalgia in several studies. Methods: In this randomized, double-blind clinical trial, cancer patients undergoing chemotherapy were assessed for neuropathy and pain using the Patient Neurotoxicity Questionnaire and McGill Pain Questionnaire at baseline, 6 weeks, and 12 weeks. Patients were randomized to receive either duloxetine (Group A: 30 mg daily, increasing to 60 mg daily after 1 week), venlafaxine (Group B: 37.5 mg daily, increasing to 75 mg daily after 1 week), or a placebo (Group C). Results: Among 141 randomized patients (61% female; mean age 64.4 years), no significant difference in pain scores was observed between groups at the primary endpoint of week 6 ( P = 0.59). At the secondary endpoint of week 12, a statistically significant difference between groups emerged ( P = 0.03), driven by a reduction in pain scores in the duloxetine group compared with placebo ( post hoc P = 0.03). Within-group reductions were significant for both duloxetine ( P = 0.002) and venlafaxine ( P = 0.007) at 12 weeks. Conclusion: This trial did not meet its primary endpoint at 6 weeks with duloxetine or venlafaxine compared to placebo. Secondary analyses at 12 weeks suggest that only duloxetine may provide clinically meaningful symptom relief. Venlafaxine findings remain inconclusive, as within-group improvements did not translate into statistically significant between-group superiority.
- 27 July 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (8) , e71757
Frequency, Demographic and Clinical Characteristics of Pediatric Lophomoniasis: A Cross‐Sectional Study in Northern Iran
Background: Lophomoniasis is an emerging respiratory infection, but its clinical and epidemiological characteristics in pediatric populations remain poorly defined. This study aimed to determine the prevalence and describe the clinical, radiological, and bronchoscopic features of lophomoniasis in children admitted to a pediatric respiratory referral center. Material and Methods: A cross‐sectional study was conducted at Taleghani Pediatric Hospital. The study enrolled 121 pediatric patients admitted with persistent respiratory symptoms and a clinical indication for bronchoscopy. Bronchoalveolar lavage (BAL) samples were used to diagnose lophomoniasis. Results: The frequency of lophomoniasis was 18.1% (22/121 patients). Mean age of lophomonas ‐positive patients was 8.03 years and they were primarily female (54.5%). Common presenting symptoms included cough (86.4%), fever (68.2%), and sputum (54.5%). Key findings included consolidation on radiography (54.5%), increased bronchial wall thickness on bronchoscopy (63.6%), and anemia (95.5%) in laboratory results. A significant majority (72.7%) had underlying diseases, most commonly cystic fibrosis (31.8%) and tuberculosis (13.6%). Statistical analysis revealed that lophomoniasis was significantly associated with the presence of any underlying disease ( p = 0.001). Other significant associations were observed with positive CRP ( p = 0.024), leukocytosis ( p = 0.025), radiographic consolidation ( p = 0.018), and the presence of a hydatid cyst ( p = 0.041). Demographic factors such as age, gender, ethnicity, and place of residence were not significantly associated with the infection. Conclusion: Lophomonasis is a frequent condition among children with chronic respiratory symptoms requiring bronchoscopy. Its strong association with underlying respiratory diseases highlights the need for systematic screening in this vulnerable population. Bronchoscopy with BAL is a valuable diagnostic tool, particularly when specific clinical and radiological findings are present.
- 27 July 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (8) , e71757
Frequency, Demographic and Clinical Characteristics of Pediatric Lophomoniasis: A Cross‐Sectional Study in Northern Iran
Background: Lophomoniasis is an emerging respiratory infection, but its clinical and epidemiological characteristics in pediatric populations remain poorly defined. This study aimed to determine the prevalence and describe the clinical, radiological, and bronchoscopic features of lophomoniasis in children admitted to a pediatric respiratory referral center. Material and Methods: A cross‐sectional study was conducted at Taleghani Pediatric Hospital. The study enrolled 121 pediatric patients admitted with persistent respiratory symptoms and a clinical indication for bronchoscopy. Bronchoalveolar lavage (BAL) samples were used to diagnose lophomoniasis. Results: The frequency of lophomoniasis was 18.1% (22/121 patients). Mean age of lophomonas ‐positive patients was 8.03 years and they were primarily female (54.5%). Common presenting symptoms included cough (86.4%), fever (68.2%), and sputum (54.5%). Key findings included consolidation on radiography (54.5%), increased bronchial wall thickness on bronchoscopy (63.6%), and anemia (95.5%) in laboratory results. A significant majority (72.7%) had underlying diseases, most commonly cystic fibrosis (31.8%) and tuberculosis (13.6%). Statistical analysis revealed that lophomoniasis was significantly associated with the presence of any underlying disease ( p = 0.001). Other significant associations were observed with positive CRP ( p = 0.024), leukocytosis ( p = 0.025), radiographic consolidation ( p = 0.018), and the presence of a hydatid cyst ( p = 0.041). Demographic factors such as age, gender, ethnicity, and place of residence were not significantly associated with the infection. Conclusion: Lophomonasis is a frequent condition among children with chronic respiratory symptoms requiring bronchoscopy. Its strong association with underlying respiratory diseases highlights the need for systematic screening in this vulnerable population. Bronchoscopy with BAL is a valuable diagnostic tool, particularly when specific clinical and radiological findings are present.
- Open Access
- 16 March 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1) , 37
Uncommon cardiovascular and pulmonary complications prompt diagnosis of primary Sjögren's syndrome: a case report and literature review
Introduction: Pulmonary involvement is the most common extra-glandular manifestation in primary Sjögren’s syndrome (pSS), adversely affecting patient prognosis. Nonspecific interstitial pneumonia, pulmonary embolism, and pulmonary hypertension are infrequently observed in patients with Sjögren’s syndrome, thereby complicating the diagnostic process. Case report: This case report presents a patient with a five-year history of pulmonary fibrosis, referred for worsening shortness of breath. The patient was later diagnosed with pSS, which included pulmonary involvement, pulmonary hypertension, and pulmonary thrombosis. Conclusion: This case highlights the need to recognize pulmonary manifestations of pSS and the complexities of managing patients, especially regarding complications like pulmonary hypertension and thrombosis. Pulmonary disease treatment in pSS should be guided by the extent and progression of pulmonary involvement, utilizing glucocorticoids or other immunosuppressive drugs based on experiences from other immune-mediated diseases.
- 16 March 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1) , 37
Open AccessUncommon cardiovascular and pulmonary complications prompt diagnosis of primary Sjögren's syndrome: a case report and literature review
Introduction: Pulmonary involvement is the most common extra-glandular manifestation in primary Sjögren’s syndrome (pSS), adversely affecting patient prognosis. Nonspecific interstitial pneumonia, pulmonary embolism, and pulmonary hypertension are infrequently observed in patients with Sjögren’s syndrome, thereby complicating the diagnostic process. Case report: This case report presents a patient with a five-year history of pulmonary fibrosis, referred for worsening shortness of breath. The patient was later diagnosed with pSS, which included pulmonary involvement, pulmonary hypertension, and pulmonary thrombosis. Conclusion: This case highlights the need to recognize pulmonary manifestations of pSS and the complexities of managing patients, especially regarding complications like pulmonary hypertension and thrombosis. Pulmonary disease treatment in pSS should be guided by the extent and progression of pulmonary involvement, utilizing glucocorticoids or other immunosuppressive drugs based on experiences from other immune-mediated diseases.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Pulmonology
- Vol. 2026 (1) , 8752504
Clinical Insights and Diagnostic Challenges of Pulmonary Lophomoniasis in a Sarcoidosis Patient: A Case Report
Introduction: In recent years, reports of patients with lophomoniasis infection have increased. This upward trend has been especially evident among patients with underlying conditions or those undergoing immunosuppressive therapy. Case Presentation: We present a 38‐year‐old Fars female patient of Fars ethnicity with a 2‐year medical history of sarcoidosis who was investigated due to persistent respiratory symptoms that were unresponsive to outpatient treatment. The patient was receiving immunosuppressive medication for her condition. During hospitalization, computed tomography of the lungs revealed the presence of cystic bronchiectasis in the lingula and linear atelectasis. Bronchoscopy was performed, and a bronchoalveolar lavage (BAL) sample was taken. Microscopic analysis of the sample showed the presence of Lophomonas spp. Conclusion: Sarcoidosis, an immunodeficiency‐related inflammatory disease, may increase susceptibility to parasitic infections. Pulmonary lophomoniasis, mostly presenting with nonspecific symptoms similar to other pneumonias, can lead to delayed diagnosis and poor outcomes. Physicians should consider lophomoniasis in immunocompromised patients due to differences in its nature, diagnostic approach, and treatment.
- 1 January 2026
- Published by Wiley in Case Reports in Pulmonology
- Vol. 2026 (1) , 8752504
Open AccessClinical Insights and Diagnostic Challenges of Pulmonary Lophomoniasis in a Sarcoidosis Patient: A Case Report
Introduction: In recent years, reports of patients with lophomoniasis infection have increased. This upward trend has been especially evident among patients with underlying conditions or those undergoing immunosuppressive therapy. Case Presentation: We present a 38‐year‐old Fars female patient of Fars ethnicity with a 2‐year medical history of sarcoidosis who was investigated due to persistent respiratory symptoms that were unresponsive to outpatient treatment. The patient was receiving immunosuppressive medication for her condition. During hospitalization, computed tomography of the lungs revealed the presence of cystic bronchiectasis in the lingula and linear atelectasis. Bronchoscopy was performed, and a bronchoalveolar lavage (BAL) sample was taken. Microscopic analysis of the sample showed the presence of Lophomonas spp. Conclusion: Sarcoidosis, an immunodeficiency‐related inflammatory disease, may increase susceptibility to parasitic infections. Pulmonary lophomoniasis, mostly presenting with nonspecific symptoms similar to other pneumonias, can lead to delayed diagnosis and poor outcomes. Physicians should consider lophomoniasis in immunocompromised patients due to differences in its nature, diagnostic approach, and treatment.
- Open Access
- 26 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (1) , 698-717
Effect of probiotics and synbiotics on antimicrobial resistance in frequent infections: a systematic review of clinical trials
Background: Antibiotic resistance and recurrent infections, driven by increased antibiotic use, represent a global health problem. This study aims to evaluate the effect of probiotics and synbiotics consumption on antibiotic resistance in common infections. Methods: A systematic search was performed on international electronic databases (PubMed/Medline, Scopus, and Web of Science) using predefined keywords to identify relevant clinical trials published prior to 1 March 2025. Study quality was assessed, and the PRISMA 2020 guideline was followed. Results: In our systematic review, 47 studies were included. Twenty studies reported positive effects on antibiotic resistance, eradication rates, and recurrence, particularly in gastrointestinal infections. In contrast, 10 studies reported no effect, and 2 indicated a negative effect of these interventions on infection recurrence and antibiotic resistance. In three studies focusing on children, probiotics significantly lowered the risk of urinary tract infection (UTI) recurrence and antibiotic resistance. However, an adult study found that probiotics had minimal effect on UTI recurrence. Four studies examined the effect of probiotics on respiratory infections in both children and adults, showing improvements in antibiotic resistance outcomes. Three studies involving preterm infants found that probiotics could modify their gut microbiome composition, with two studies confirming this effect. Conclusion: Our study indicates that incorporating probiotics and synbiotics into common infection therapy could improve antibiotic resistance, eradicate rates, minimize side effects, and boost treatment compliance. However, concerns remain regarding the potential transfer of antibiotic resistance genes via probiotics.
- 26 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (1) , 698-717
Open AccessEffect of probiotics and synbiotics on antimicrobial resistance in frequent infections: a systematic review of clinical trials
Background: Antibiotic resistance and recurrent infections, driven by increased antibiotic use, represent a global health problem. This study aims to evaluate the effect of probiotics and synbiotics consumption on antibiotic resistance in common infections. Methods: A systematic search was performed on international electronic databases (PubMed/Medline, Scopus, and Web of Science) using predefined keywords to identify relevant clinical trials published prior to 1 March 2025. Study quality was assessed, and the PRISMA 2020 guideline was followed. Results: In our systematic review, 47 studies were included. Twenty studies reported positive effects on antibiotic resistance, eradication rates, and recurrence, particularly in gastrointestinal infections. In contrast, 10 studies reported no effect, and 2 indicated a negative effect of these interventions on infection recurrence and antibiotic resistance. In three studies focusing on children, probiotics significantly lowered the risk of urinary tract infection (UTI) recurrence and antibiotic resistance. However, an adult study found that probiotics had minimal effect on UTI recurrence. Four studies examined the effect of probiotics on respiratory infections in both children and adults, showing improvements in antibiotic resistance outcomes. Three studies involving preterm infants found that probiotics could modify their gut microbiome composition, with two studies confirming this effect. Conclusion: Our study indicates that incorporating probiotics and synbiotics into common infection therapy could improve antibiotic resistance, eradicate rates, minimize side effects, and boost treatment compliance. However, concerns remain regarding the potential transfer of antibiotic resistance genes via probiotics.
- Open Access
- 23 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7095-7104
Investigation of fungal nosocomial infections and antimicrobial drug resistance pattern after open-heart surgery; a cross-sectional study
Background: Nosocomial fungal infections are a significant cause of mortality in hospitalized patients, particularly those with immune system defects. Surgical site infections (SSIs) following open-heart procedures cause significant problems for patients and treatment systems. Methods: In this cross-sectional study, we analyzed wound culture samples from the sternum, urine cultures, blood cultures, and cultures from catheters of 310 hospitalized patients (mean age: 42 ± 10.23 years), collected between March 2018 and February 2022. Antimicrobial susceptibility tests were conducted using the Kirby-Bauer diffusion disk method. We assessed antimicrobial resistance alongside laboratory indicators related to infections. Results: The highest rate of infection was urinary tract infection (13.54%) septicemia (10%), pneumonia (4.83%), SSIs (3.87%), and catheter-induced infection (1.29%), respectively. The mortality rate was 6.4%. All fungal strains were Candida spp., and six strains were resistant to fluconazole. All Candida species were sensitive to amphotericin B. The highest amount of antibiotic resistance is related to ceftazidime (51.3%), followed by ceftriaxone (43.2%), and the lowest amount is related to nitrofurantoin and sulfamethoxazole/trimethoprim (17.6%). Conclusions: The non -Candida albicans species were the most abundant species identified in candidiasis. Cardiovascular diseases, chronic kidney disease, hypertension, diabetes, and obesity increase the rate of SSI in patients.
- 23 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7095-7104
Open AccessInvestigation of fungal nosocomial infections and antimicrobial drug resistance pattern after open-heart surgery; a cross-sectional study
Background: Nosocomial fungal infections are a significant cause of mortality in hospitalized patients, particularly those with immune system defects. Surgical site infections (SSIs) following open-heart procedures cause significant problems for patients and treatment systems. Methods: In this cross-sectional study, we analyzed wound culture samples from the sternum, urine cultures, blood cultures, and cultures from catheters of 310 hospitalized patients (mean age: 42 ± 10.23 years), collected between March 2018 and February 2022. Antimicrobial susceptibility tests were conducted using the Kirby-Bauer diffusion disk method. We assessed antimicrobial resistance alongside laboratory indicators related to infections. Results: The highest rate of infection was urinary tract infection (13.54%) septicemia (10%), pneumonia (4.83%), SSIs (3.87%), and catheter-induced infection (1.29%), respectively. The mortality rate was 6.4%. All fungal strains were Candida spp., and six strains were resistant to fluconazole. All Candida species were sensitive to amphotericin B. The highest amount of antibiotic resistance is related to ceftazidime (51.3%), followed by ceftriaxone (43.2%), and the lowest amount is related to nitrofurantoin and sulfamethoxazole/trimethoprim (17.6%). Conclusions: The non -Candida albicans species were the most abundant species identified in candidiasis. Cardiovascular diseases, chronic kidney disease, hypertension, diabetes, and obesity increase the rate of SSI in patients.
- Open Access
- 29 August 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (9) , e70828
Exploring Interstitial Pneumonia With Autoimmune Features: Case Study Insights and Review of Current Literature
Interstitial Pneumonia with Autoimmune Features (IPAF) refers to a subgroup of interstitial lung diseases that show autoimmune‐like characteristics but do not align with established conditions such as idiopathic pulmonary fibrosis (IPF) or recognized connective tissue diseases (CTD). In this case report, we present a 43‐year‐old woman who had a history of dry cough, decreased appetite, weight loss, and progressive shortness of breath. Initial investigations, including spirometry, autoantibody testing, and CT scan, revealed evidence of nonspecific interstitial pneumonia and positive autoantibodies. Our patient did not fully meet the CTD criteria, and based on the clinical symptoms, imaging findings, and the presence of autoantibodies, an IPAF diagnosis was made. Our patient was treated with prednisolone and mycophenolate, significantly improving her symptoms, pulmonary function, and exercise capacity during the one‐year follow‐up period. Our report mentioned the importance of considering IPAF in the differential diagnosis of patients presenting with interstitial lung disease and features of an autoimmune process. Delayed diagnosis contributes to poorer prognoses and increased disease severity among affected individuals.
- 29 August 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (9) , e70828
Open AccessExploring Interstitial Pneumonia With Autoimmune Features: Case Study Insights and Review of Current Literature
Interstitial Pneumonia with Autoimmune Features (IPAF) refers to a subgroup of interstitial lung diseases that show autoimmune‐like characteristics but do not align with established conditions such as idiopathic pulmonary fibrosis (IPF) or recognized connective tissue diseases (CTD). In this case report, we present a 43‐year‐old woman who had a history of dry cough, decreased appetite, weight loss, and progressive shortness of breath. Initial investigations, including spirometry, autoantibody testing, and CT scan, revealed evidence of nonspecific interstitial pneumonia and positive autoantibodies. Our patient did not fully meet the CTD criteria, and based on the clinical symptoms, imaging findings, and the presence of autoantibodies, an IPAF diagnosis was made. Our patient was treated with prednisolone and mycophenolate, significantly improving her symptoms, pulmonary function, and exercise capacity during the one‐year follow‐up period. Our report mentioned the importance of considering IPAF in the differential diagnosis of patients presenting with interstitial lung disease and features of an autoimmune process. Delayed diagnosis contributes to poorer prognoses and increased disease severity among affected individuals.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 12
Awareness and Attitudes of Medical Students, Interns, and Residents Toward Telemedicine in Medical Education During the COVID-19 Pandemic: Survey-Based Cross-Sectional Study From Northern Iran
BACKGROUND: Telemedicine is widely used in medical treatment and education systems. Therefore, it is essential to investigate the attitudes and awareness of medical students about it. We aimed to examine the awareness and attitudes of medical students, interns and residents toward telemedicine in medical education during the COVID-19 pandemic. METHOD: This cross-sectional study was conducted after new educational approaches were implemented due to the COVID-19 pandemic. Two questionnaires were used to assess the new educational methodologies. Participants included residents (R), interns (I), and students (S) from the internal medicine department. A census sampling method was employed, inviting all medical education members who met the entry criteria to participate. The data were analyzed descriptively, and group differences were tested using chi-square, independent samples T-test, Mann–Whitney, and Kruskal–Wallis tests. RESULT: Out of 278 medical education members eligible to participate, 249 (89.5%) completed the study. The mean score for participants’ attitudes was above 3 ( M = 3.78, SD = 0.24) indicating a generally favorable view of telemedicine. A significant gap was noted between participants’ awareness and attitudes, with residents showing the lowest scores in both areas ( P-value = .02). Our assessment revealed that “Satisfaction with the platform and facilities for e-classes” received the highest consensus from residents and interns, rated moderately agreeable by students (R: 64.5%, I: 59.7%, S: 48.8%). Responses to “Using e-learning courses alongside postcrisis face-to-face courses” and “Using e-learning courses alone postcrisis” varied among the groups (R: 58.1% and 54.9%, I: 59% and 58.2%, S: 47.6% and 45.3%). CONCLUSION: The results of this survey reveal that medical students and interns may demonstrate a favorable awareness and attitude toward telemedicine. Consequently, developing educational programs and enhancing exposure to telemedicine should be considered since these elements could be vital for the future training of medical professionals.
- 1 January 2025
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 12
Open AccessAwareness and Attitudes of Medical Students, Interns, and Residents Toward Telemedicine in Medical Education During the COVID-19 Pandemic: Survey-Based Cross-Sectional Study From Northern Iran
BACKGROUND: Telemedicine is widely used in medical treatment and education systems. Therefore, it is essential to investigate the attitudes and awareness of medical students about it. We aimed to examine the awareness and attitudes of medical students, interns and residents toward telemedicine in medical education during the COVID-19 pandemic. METHOD: This cross-sectional study was conducted after new educational approaches were implemented due to the COVID-19 pandemic. Two questionnaires were used to assess the new educational methodologies. Participants included residents (R), interns (I), and students (S) from the internal medicine department. A census sampling method was employed, inviting all medical education members who met the entry criteria to participate. The data were analyzed descriptively, and group differences were tested using chi-square, independent samples T-test, Mann–Whitney, and Kruskal–Wallis tests. RESULT: Out of 278 medical education members eligible to participate, 249 (89.5%) completed the study. The mean score for participants’ attitudes was above 3 ( M = 3.78, SD = 0.24) indicating a generally favorable view of telemedicine. A significant gap was noted between participants’ awareness and attitudes, with residents showing the lowest scores in both areas ( P-value = .02). Our assessment revealed that “Satisfaction with the platform and facilities for e-classes” received the highest consensus from residents and interns, rated moderately agreeable by students (R: 64.5%, I: 59.7%, S: 48.8%). Responses to “Using e-learning courses alongside postcrisis face-to-face courses” and “Using e-learning courses alone postcrisis” varied among the groups (R: 58.1% and 54.9%, I: 59% and 58.2%, S: 47.6% and 45.3%). CONCLUSION: The results of this survey reveal that medical students and interns may demonstrate a favorable awareness and attitude toward telemedicine. Consequently, developing educational programs and enhancing exposure to telemedicine should be considered since these elements could be vital for the future training of medical professionals.
- Open Access
- 7 November 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (12) , 7398-7401
Sinus mucocele leads to unilateral proptosis in an infant patient with cystic fibrosis: a literature review and a case report study
Introduction and importance: Cystic fibrosis (CF) is a widespread life-shortening recessive genetic disease and can present with sinus mucocele. Sinus mucocele is a rare condition, with limited prevalence data on unilateral proptosis. Case presentation: The authors present a case of a 19-month-old boy with CF who experienced worsening proptosis and exotropia in his right eye. A brain and orbit MRI revealed diffuse polypoid mucosal thickening, possible dense fungal deposit, deformity of the mid face, especially on the right side, with more prominent bulging of medical and inferior walls of the right lobe, a right ethmoidal mucocele causing ocular globe displacement, medial rectus compression, and optic nerve. An examination of the eye fundus showed disc edema and vascular congestion. Endoscopic sinus surgery successfully drained the mucocele, and treatment with antibiotics and corticosteroids led to symptom improvement and resolution of proptosis within 3 weeks. Clinical discussion: Mucoceles represent an uncommon complication associated with CF in pediatric patients. Consequently, any child presenting with this issue should undergo evaluation for CF. Investigating this infrequent condition’s underlying mechanisms and consequences may improve treatment approaches and outcomes for those impacted. Conclusion: Sinus mucocele with unilateral proptosis in CF patients is uncommon, and endoscopic sinus surgery appears to be an effective cure for this complication, even in the pediatric population at high risk, like CF patients.
- 7 November 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (12) , 7398-7401
Open AccessSinus mucocele leads to unilateral proptosis in an infant patient with cystic fibrosis: a literature review and a case report study
Introduction and importance: Cystic fibrosis (CF) is a widespread life-shortening recessive genetic disease and can present with sinus mucocele. Sinus mucocele is a rare condition, with limited prevalence data on unilateral proptosis. Case presentation: The authors present a case of a 19-month-old boy with CF who experienced worsening proptosis and exotropia in his right eye. A brain and orbit MRI revealed diffuse polypoid mucosal thickening, possible dense fungal deposit, deformity of the mid face, especially on the right side, with more prominent bulging of medical and inferior walls of the right lobe, a right ethmoidal mucocele causing ocular globe displacement, medial rectus compression, and optic nerve. An examination of the eye fundus showed disc edema and vascular congestion. Endoscopic sinus surgery successfully drained the mucocele, and treatment with antibiotics and corticosteroids led to symptom improvement and resolution of proptosis within 3 weeks. Clinical discussion: Mucoceles represent an uncommon complication associated with CF in pediatric patients. Consequently, any child presenting with this issue should undergo evaluation for CF. Investigating this infrequent condition’s underlying mechanisms and consequences may improve treatment approaches and outcomes for those impacted. Conclusion: Sinus mucocele with unilateral proptosis in CF patients is uncommon, and endoscopic sinus surgery appears to be an effective cure for this complication, even in the pediatric population at high risk, like CF patients.